These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21194081)

  • 1. [Will a vaccine against hepatitis E soon be available?].
    Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2011 Jan; 40(1):44. PubMed ID: 21194081
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccines against viral hepatitis A to E. What do we have, what effect can they have?].
    Jilg W
    Pharm Unserer Zeit; 2011 Jan; 40(1):36-43. PubMed ID: 21194080
    [No Abstract]   [Full Text] [Related]  

  • 3. Toward the development of a hepatitis E vaccine.
    Kamili S
    Virus Res; 2011 Oct; 161(1):93-100. PubMed ID: 21620908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis E vaccine].
    Li TC; Takeda N; Miyamura T
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():548-53. PubMed ID: 15453382
    [No Abstract]   [Full Text] [Related]  

  • 5. The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E.
    Dong C; Dai X; Meng JH
    Vaccine; 2007 Feb; 25(9):1662-8. PubMed ID: 17156900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis E: vaccine in a near future?].
    Moucari R; Asselah T
    Rev Med Interne; 2008 Aug; 29(8):615-7. PubMed ID: 18556093
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of the hepatitis E vaccine: from bench to field.
    Zhang J; Shih JW; Wu T; Li SW; Xia NS
    Semin Liver Dis; 2013 Feb; 33(1):79-88. PubMed ID: 23564392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine.
    Zhang J; Liu CB; Li RC; Li YM; Zheng YJ; Li YP; Luo D; Pan BB; Nong Y; Ge SX; Xiong JH; Shih JW; Ng MH; Xia NS
    Vaccine; 2009 Mar; 27(12):1869-74. PubMed ID: 19168109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on etiology and vaccines of hepatitis E].
    Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jan; 12(1):5-6. PubMed ID: 14761270
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatitis E infections as a world wide problem].
    Bäcklund P; Raahenmaa M
    Duodecim; 2005; 121(22):2443-7. PubMed ID: 16457075
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
    Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
    Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection.
    Kamili S; Spelbring J; Carson D; Krawczynski K
    J Infect Dis; 2004 Jan; 189(2):258-64. PubMed ID: 14722891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Hepatitis E Vaccine.
    Zhang J; Zhao Q; Xia N
    Adv Exp Med Biol; 2016; 948():223-246. PubMed ID: 27738988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U.S. Military sponsored vaccine trials and la resistance in Nepal.
    Andrews J
    Am J Bioeth; 2005; 5(3):W1-3. PubMed ID: 16006352
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis E: a neglected threat.
    Myint KS; Gibbons RV
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):211-2. PubMed ID: 17658568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
    Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA
    Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis E vaccine: not a moment too soon.
    Holmberg SD
    Lancet; 2010 Sep; 376(9744):849-51. PubMed ID: 20728933
    [No Abstract]   [Full Text] [Related]  

  • 18. Perspectives of vaccination against hepatitis E.
    Safary A
    Intervirology; 2001; 44(2-3):162-6. PubMed ID: 11509877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus.
    Zhou YH; Purcell RH; Emerson SU
    Vaccine; 2005 May; 23(24):3157-65. PubMed ID: 15837215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autochthonous hepatitis E in France].
    Buisson Y; Nicand E
    Bull Acad Natl Med; 2006; 190(4-5):973-80. PubMed ID: 17195621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.